Human HiQCell osteoarthritis cell therapy is now available
Delivering quality in regenerative medicine
HiQCell and AdiCell use regenerative cells from the patient’s own fat
Pioneering the analysis of adipose derived cells and cell secretions
AdiCell: The highest quality cellular treatment for small & large animals
Regeneus is an emerging leader in using the regenerative capacities of adipose-derived cells to develop innovative cell therapies for people and animals.
We're an Australian company developing proprietary technologies for the manufacture of in-clinic and off-the-shelf cell therapies from adipose tissue.
Human Health
The HiQCell therapy is now commercially available to treat human osteoarthritis and other musculoskeletal conditions. HiQCell is prepared in-clinic using the patient's own regenerative cells taken from adipose (fat) tissue. The entire procedure is performed within 3-4 hours by an accredited medical specialist.
Animal Health
Since 2008, leading veterinarians in Australia, New Zealand and the United Kingdom have used AdiCell to treat canine osteoarthritis and more recently to treat equine tendon and ligament injuries. AdiCell is prepared in-clinic using the animal's own adipose-derived regenerative cells.